Tru-D News, Tru-D Technology, Uncategorized

Tru-D and C. diff

Clostridium difficile or C. diff as it’s commonly known, is one of the most deadly and hard-to-kill superbugs. Tru-D SmartUVC uses chemical-free, environmentally-friendly UVC energy to kill C. diff and other deadly pathogens. UVC light has been proven to reduce the spread of C. diff in hospitals and health care

Read More
Posted 05.24.17
  • Share

Industry News, Studies, Tru-D News, Tru-D Technology, Uncategorized

BETR-D Study Shows 11% C. diff Reduction

Shield Design with 11% Hospital C. Diff Reduction

The Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study is the first and only randomized clinical trial on UV disinfection. The study’s primary outcome showed that enhanced terminal room disinfection strategies that utilized Tru-D reduced the risk of acquisition and infection by a cumulative 30 percent among patients who entered the

Read More
Posted 04.26.17
  • Share

Industry News, Press Releases, Tru-D News, Tru-D Technology, Uncategorized

Tru-D SmartUVC to Participate as a Sponsor of the 5th Annual International C. diff Awareness Conference & Health EXPO

Tru-D SmartUVC, a leader in the UV disinfection industry, has announced its commitment as a sponsor of the 5th Annual International C. diff Awareness Conference and Health Expo. The C. diff Foundation’s mission is to educate and advocate for the prevention, treatment and environmental safety of C. diff infections worldwide.

Read More
Posted 03.30.17
  • Share

Disinfection, HAIs, Tru-D Technology, Uncategorized

Getting to Know Superbugs: C. diff

Clostridium difficile, or C.diff as it’s commonly known, is one of the fastest growing superbugs in the world. According to the Centers for Disease Control, there are more than 500,000 C. diff cases reported and more than 29,000 C. diff-related deaths each year within 30 days of diagnosis. C. diff

Read More
Posted 06.29.16
  • Share

Disinfection, HAIs, Industry News, Tru-D News, Tru-D Technology, Uncategorized

Study: 3-Step C. Diff Intervention Cuts Infection Rates 89%

Becker’s Clinical Quality & Infection Control reported the success of a study conducted at a Veterans Affairs hospital involving Tru-D that reduced the amount of C. difficile rates by 89%. A three-step intervention process was used that included: standard environmental services cleaning procedures and supervisory CDI room clearance; an additional

Read More
Posted 04.10.13
  • Share

Never miss the latest in UV news.
Subscribe to UVC360 today.

Sign Up »